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Abstract
Background: Sciatic nerve injuries often cause partial or total loss of motor, sensory and autonomic functions due to the
axon discontinuity, degeneration, and eventual death which finally result in substantial functional loss and decreased
quality of life. Nerve growth factor (NGF) plays a critical role in peripheral nerve regeneration. However, the lack of efficient
NGF delivery approach limits its clinical applications. We reported here by fusing with the N-terminal domain of agrin (NtA),
NGF-b could target to nerve cells and improve nerve regeneration.
Methods: Laminin-binding assay and sustained release assay of NGF-b fused with NtA (LBD-NGF) from laminin in vitro were
carried out. The bioactivity of LBD-NGF on laminin in vitro was also measured. Using the rat sciatic nerve crush injury model,
the nerve repair and functional restoration by utilizing LBD-NGF were tested.
Findings: LBD-NGF could specifically bind to laminin and maintain NGF activity both in vitro and in vivo. In the rat sciatic
nerve crush injury model, we found that LBD-NGF could be retained and concentrated at the nerve injury sites to promote
nerve repair and enhance functional restoration following nerve damages.
Conclusion: Fused with NtA, NGF-b could bind to laminin specifically. Since laminin is the major component of nerve
extracellular matrix, laminin binding NGF could target to nerve cells and improve the repair of peripheral nerve injuries.
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Introduction
Sciatic nerve injuries are often caused by injections, gunshot
wounds, lacerations, contusions, compressions, and iatrogenic
causes [1,2]. Injuries to sciatic nerves cause partial or total loss of
motor, sensory and autonomic functions due to the axon
discontinuity, degeneration, and eventual death which finally result
in substantial functional loss and decreased quality of life [3,4].
Functional deficits caused by nerve injuries can be compensated by
regeneration of peripheral nerves. However, clinical and experi-
mental evidences show that the regeneration is usually far more
difficult and the results are far from satisfactory, especially after
severe injuries [3,5]. Numerous therapeutic interventions, mostly
pharmacotherapeutic, have been tested to enhance functional
recovery after sciatic nerve injuries. The identification of neuro-
trophic factors offers molecular therapy as a potential approach to
enhance nerveregeneration.Amongtheneurotrophicfactors,nerve
growth factor (NGF) plays a critical role.
NGF promotes proliferation and differentiation of neurons, and
also modulates the repair of injured nerves [6,7]. It has been
reported that NGF was upregulated in anticipation of the arrival
of a regenerating sprout during the peripheral nerve regeneration
[8]. The administration of recombinant NGF protein into injured
nerves has been shown to promote nerve repair and enhance
functional restoration following nerve damages [9]. However NGF
simply given in solution is difficult to be retained at the injury sites
because of its rapid diffusion in body fluids. Therefore, it requires
periodic injection of NGF which is impractical and expensive, and
excessive doses may also evoke undesirable side effects [10–12]. To
solve these problems, many groups are working on developing
NGF delivery to the nervous system via drug delivery systems [13]
or transplantation of cells with/without encapsulation [14]. These
systems should be improved with regard to release control, dosing,
efficacy and safety.
Laminin is the ubiquitous component of the tight network of
glycoproteins, collagen IV and proteoglycans in basement
membranes [15]. Laminin is mainly produced by Schwann cells
and widely dispersed in the peripheral nervous system (PNS)
[16,17]. After peripheral nerve injuries, laminin is significantly
upregulated at the injury sites by Schwann cells and may foster
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6180axonal regeneration [18,19]. Thus, laminin could be a suitable
target for the delivery of exogenous NGF to repair PNS injuries.
Agrin is a key organizer of postsynaptic differentiation at the
neuromuscular junction. The binding of agrin to laminin is
required for its localization to synaptic basal lamina and other
basement membranes [20]. Previous studies have demonstrated
that the high-affinity interaction with the coiled-coil domain of
laminin was mediated by N-terminal domain of agrin (NtA) [21].
Taking advantage of this laminin-binding domain of NtA, we
produced a tripartite fusion protein to obtain laminin binding
NGF-b which contains (i) the primary sequence of the mature
NGF-b, (ii) NtA as a laminin-binding domain, and (iii) a
66histidine (His) purification tag. This fusion protein was named
as laminin binding domain fused NGF-b (LBD-NGF). We also
produced a native NGF-b without NtA (NAT-NGF). We
demonstrated that the LBD-NGF could specifically bind to
laminin and maintain NGF activity both in vitro and in vivo.I n
the rat sciatic nerve crush injury model, LBD-NGF could target to
the native nerve extracellular matrix component laminin, and
could be retained and concentrated at the nerve injury sites to
improve peripheral nerve regeneration.
Results
LBD-NGF could bind to laminin and be sustained
released in vitro
We measured the in vitro laminin-binding activities of NAT-
NGF and LBD-NGF by ELISA. From the results, we found at
each indicated point the OD405 of LBD-NGF was significantly
higher than that of NAT-NGF, indicating that the retained LBD-
NGF on laminin was more than that of NAT-NGF (n=6,
P,0.01) (Figure 1A).
Using the binding curve, we calculated the dissociation constant
Kd values of NAT-NGF and LBD-NGF to laminin by Scatchard
analysis. The slope of the resulting straight line equals 21/Kd
(Figure 1B). The Kd value for the binding of NAT-NGF and LBD-
NGF was measured as 6.25610
24 M and 7.25610
26 M respec-
tively. The lower Kd value of LBD-NGF to laminin indicated that
LBD-NGF bound to laminin specifically.
Using ELISA assay, we found the membrane prepared from pig
amnion was rich in laminin content (Figure 1C). In the in vitro
release experiment, sustained release of NAT-NGF and LBD-
NGF was followed up to 8 days (Figure 1D). We found NAT-NGF
was quickly released at the first day, whereas LBD-NGF could
gradually be released from laminin. During the first 6 days, LBD-
NGF retained on laminin was significantly higher than NAT-NGF
(n=6, P,0.05). These results showed that LBD-NGF could be
sustained released from laminin in vitro.
LBD-NGF maintained higher bioactivity on laminin in
vitro
We tested the bioactivities of NAT-NGF and LBD-NGF using
PC 12 cell lines. Stimulated by NAT-NGF or LBD-NGF, the
neurite outgrowth of PC 12 cells was observed after 24 h
incubation. The percentage of cells with neurite outgrowth
increased in a dose-dependent manner, but there was no
significant difference among them at each concentration
(Figure 2A). The application of NAT-NGF and LBD-NGF to
Figure 1. Laminin-binding and sustained release assay of NAT-NGF and LBD-NGF from laminin in vitro. (a) Binding curves of NAT-NGF
and LBD-NGF to laminin measured by ELISA assay. (b) Kd values for laminin to NAT-NGF and LBD-NGF were calculated using Scatchard analysis. (c)
Detection of laminin content in the pig amnion by ELASA assay. (d) Release curves of NAT-NGF and LBD-NGF from laminin in vitro.n=6 ,* ,P ,0.05, **,
P,0.01, determined by two-tailed student’s t-test.
doi:10.1371/journal.pone.0006180.g001
Improving Nerve Repair by NGF
PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6180PC12 cell lines also significantly increased cell survival. The dose-
response curves of NAT-NGF and LBD-NGF were similar
(Figure 2B). There was no significant difference of activity at each
concentration. Thus, the bioactivity of LBD-NGF was not affected
by fusing with the LBD peptide.
We then measured the bioactivity of NGF on laminin in vitro.
The results showed at the concentration range of 0.37–6.00 mM,
more cells with neurite outgrowth were founded in the LBD-NGF
group than in the NAT-NGF group (n=6, P,0.05) (Figure 2C).
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay also showed that there were more living cells in the
LBD-NGF group than in NAT-NGF group (n=6, P,0.05)
(Figure 2D). These results showed that LBD-NGF maintained
higher bioactivity after bound to laminin.
LBD-NGF retained at the injury sites of sciatic nerves
We tested laminin content in the rat sciatic nerve. Immunohis-
tochemistry showed the distribution of laminin in the extracellular
matrix of rat sciatic nerves (Figure 3A). Using western-blotting
analysis, we identified that rat sciatic nerves had rich laminin
content (Figure 3B).
We evaluated whether LBD-NGF could be retained at the
injury sites of sciatic nerves. Three hours and twelve hours after
injection of NAT-NGF or LBD-NGF, the sciatic nerve proteins
were extracted and the retained NGF was assessed by western-
blotting. At 3 h after injection, the level of exogenous LBD-NGF
was significantly higher than that of NAT-NGF (n=3, P,0.05)
(Figure 3C). At 12 h after injection, NAT-NGF couldn’t be
detected by western-blotting. However, LBD-NGF could still be
detected, indicating LBD-NGF was specifically retained and
enriched at the injury sites of sciatic nerves (Figure 3C).
LBD-NGF promoted functional recovery by walking track
analysis
At day 0 after injury, there was no difference among the groups
of the control, NAT-NGF, and LBD-NGF (n=6, P.0.05).
Following several weeks after injury, the sciatic functional index
(SFI) values were significantly increased in groups of NAT-NGF
and LBD-NGF compared with the control (n=6, P,0.01). At day
35, 42, 49 and 56, there were also significant differences between
groups of NAT-NGF and LBD-NGF (n=6, P,0.01) (Figure 4A).
Electrophysiological evaluation
The results showed after injury, the nerve conduction velocity
(NCV) was significantly decreased (n=6, P,0.01) (Figure 4B), and
then restored. At week 4 after injury, NCV of LBD-NGF group
showed significant restoration compared with the control (n=6,
P,0.05) (Figure 4C). At week 8, NCV was significantly restored in
groups of NAT-NGF (n=6, P,0.05) and LBD-NGF (n=6,
P,0.01) compared with the control. But there was no significant
difference between the groups of NAT-NGF and LBD-NGF
(Fig. 4C). At week 12 after injury, there were significant differences
among the three groups of the control, NAT-NGF and LBD-NGF
(n=6, P,0.05) (Figure 4C).
The distal compound muscle action potential (DCMAP) was
also significantly decreased after injury (n=6, P,0.01) (Figure 4D).
At week 8, DCMAP in group of LBD-NGF was significantly
restored compared with groups of NAT-NGF and the control
Figure 2. Bioactivity comparison of NAT-NGF and LBD-NGF in vitro. (a) Effect of NAT-NGF and LBD-NGF on neurite outgrowth in PC12 cells.
(b) Effect of NAT-NGF and LBD-NGF on cell survival in PC12 cells by MTT assay. (c) Percentage of PC12 cells with neurite outgrowth on laminin
stimulated by NAT-NGF and LBD-NGF. (d) PC12 cell survival on laminin stimulated by NAT-NGF and LBD-NGF was determined by MTT assay. n=6, *,
P,0.05, **, P,0.01, determined by two-tailed student’s t-test.
doi:10.1371/journal.pone.0006180.g002
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significant differences among the groups of the control, NAT-NGF
and LBD-NGF (n=6, P,0.05), and LBD-NGF showed the
highest value among the three groups (Figure 4E).
Histological analysis
The longitudinal sections at the injury sites of sciatic nerves were
analyzed by hematoxylin and eosin (H.E.) staining. The results
showed that at week 8 after injury, there was little nerve
regeneration in the control group (Figure 5A), while significant
nerve regeneration and apparent linear ordered structures were
seen in the groups of NAT-NGF and LBD-NGF (Figure 5B,C).
The group of LBD-NGF showed better regeneration compared
with NAT-NGF.
Axonal regeneration was investigated by staining neurofilament-
positive axons in transverse sections at the injury sites of sciatic
nerves. Results showed that LBD-NGF promoted more axonal
regeneration and nerve repair at week 8 after injury (Figure 5E–
H). The statistical analysis revealed that at week 4 after injury,
neurofilament-positive area in the LBD-NGF group significantly
increased compared with the control (n=6, P,0.01) (Figure 5M).
At week 8 and 12 after injury, there were significant differences in
neurofilament-positive area among the groups of the control,
NAT-NGF and LBD-NGF, and the group of LBD-NGF had the
highest value among the three groups (n=6, P,0.05) (Figure 5M).
Immunostaining with the glia/Schwann cell marker S100 also
demonstrated that LBD-NGF increased S100 expression and
improved Schwann cell regeneration in response to sciatic nerve
crush injury at week 8 after injury compared with the control
(Figure 5I–L). The statistical analysis revealed that at week 4,
S100-positive area in the LBD-NGF group significantly
increased compared with the control and NAT-NGF (n=6,
P,0.01) (Figure 5N). At week 8 and 12, there were significant
increases in neurofilament-positive area between the groups of
NAT-NGF and LBD-NGF compared with the control (n=6,
P,0.05) (Figure 5N). There were also significant differences
between the groups of NAT-NGF and LBD-NGF (n=6,
P,0.01) (Figure 5N).
Remyelination of sciatic nerves
Transverse semi-thin sections at the injury sites of sciatic nerves
were analyzed by Toluidine blue staining. The results showed at
week 4 after injury, a large number of well-myelinated axons with
large diameter were observed in the group of LBD-NGF
(Figure 6A–D).
Ultra-thin sections were observed under the transmission
electron microscope. The results showed at week 12 after injury,
the thickness of the myelin sheath around the axons was the
greatest for native nerves, followed by LBD-NGF and then NAT-
NGF treated nerves. The thickness of the myelin sheath in the
control group was the thinnest (Figure 6E–H).
The statistical analysis revealed that at week 4 after injury, there
were significant differences in the number of myelinated axons
among the groups of the control, NAT-NGF and LBD-NGF
(n=6, P,0.05) (Figure 6I). However, at week 8 and 12, there was
no significant difference among the three groups (n=6, P.0.05)
(Figure 6I).
In the statistical analysis of the myelinated axon diameter, we
found at week 4, myelinated axon diameter was significantly larger
in groups of NAT-NGF (n=6, P,0.05) and LBD-NGF (n=6,
P,0.01) compared with the control (Figure 6J). But there was no
significant difference between the groups of NAT-NGF and LBD-
NGF (Figure 6J). At week 8 and 12 after injury, myelinated axon
diameter of LBD-NGF group was significant larger than that of
NAT-NGF (n=6, P,0.05) (Figure 6J).
We also evaluated the thickness of myelin sheath by Image-Pro
Plus software (Media Cybernetics). The statistical analysis revealed
that at each time point, the myelin sheath thickness was
significantly greater in the LBD-NGF group compared with the
control (n=6, P,0.01) (Figure 6K). At week 8 and 12, there were
also significant differences in myelin sheath thickness between the
groups of NAT-NGF and LBD-NGF (n=6, P,0.01) (Figure 6K).
Discussion
NGF plays a critical role in nerve injury repair. However in
practice, NGF simply delivered in solution is difficult to be
retained at the injury sites due to its rapid diffusion in extracellular
fluids. In order to maintain NGF concentration, multiple
injections are needed. However, they would increase cost and
surgical risks. In addition, the excessive NGF at the injection sites
and the diffusion of NGF may cause possible adverse effects. Thus,
a delicate control of NGF both in dosage and in localization is
critical to apply NGF safely and efficiently.
One of the strategies is to incorporate NGF into polymeric
materials and then implant directly into the targeted tissue sites
[22,23]. It could maintain growth factor stability and prolong
Figure 3. Detection of laminin content and the sustained NAT-NGF and LBD-NGF in vivo. (a) Immunohistochemistry of laminin in the rat
sciatic nerve. (b) Detection of laminin content in the sciatic nerve by western-blotting analysis. (c) Detection of sustained NAT-NGF and LBD-NGF at
the injury sites of sciatic nerves in vivo by western-blotting analysis.
doi:10.1371/journal.pone.0006180.g003
Improving Nerve Repair by NGF
PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6180Figure 4. Functional recovery after sciatic nerve injury. (a) Measurements made from walking track prints were then submitted to SFI. (b) NCV
evaluation before and immediately after sciatic nerve injury. (c) NCV evaluation at weeks 4, 8 12 after the sciatic nerve injury. (d) DCMAP evaluation
before and immediately after sciatic nerve injury. (e) DCMAP evaluation at weeks 4, 8 12 after the sciatic nerve injury. n=6, *, P,0.05, **, P,0.01,
determined by two-tailed student’s t-test.
doi:10.1371/journal.pone.0006180.g004
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concern. In addition to polymer-based delivery systems, another
approach to providing extended delivery of NGF is by using
genetically-engineered cells, such as primary fibroblasts [24],
polymer-encapsulated cell lines [25], or neural stem cell lines [26].
These strategies also allowed a prolonged delivery of NGF, but the
safety of the method and the long-term NGF expression by
transgene still need to be determined. Moreover, the delivered
NGF doses that depend on the cell survival and the stability of the
transfection could be difficult to control in a precise manner. At
present, NGF delivery and cell transplantation could potentially be
combined with other synthetic biodegradable scaffolds made of the
poly (a-hydroxy acid) family of polymers [27] and of natural
scaffolds such as laminin-fibronectin double coated collagen [28]
used in nerve regeneration.
Laminin is widely dispersed in the peripheral nervous system
[16,17]. It has been shown that laminin-2 was a major matrix
component of the PNS which could induce cell spreading and/or
myelination [29]. It affects neuronal behavior, including prolifer-
ation, migration, target recognition, neurite outgrowth, and
central synaptic differentiation [30,31]. After peripheral nerve
injuries, Schwann cells play an indispensable role in promoting
regeneration by elaborating basement membrane containing
extracellular matrix proteins, such as laminin [19]. Therefore,
laminin could be a potential target for NGF which could be
retained and enriched at the injury sites, enhance the efficacy of
nerve regeneration.
Agrin is a key organizer of acetylcholine receptor (AChR)
clustering at the neuromuscular junction. Binding of agrin to
laminin requires NtA, which comprises the first 135 amino acids.
This region mediates high-affinity interaction with the coiled-coil
domain of laminin [21]. Thus, we fused NtA as a laminin-binding
domain to NGF to specifically bind LBD-NGF to laminin. In
order to validate its targeting effects, the laminin-binding activity
of LBD-NGF was tested in vitro. As expected, LBD-NGF showed
specific laminin-binding capacity compared with NAT-NGF
which reflected by the lower Kd value. From the sustained release
experiment, NAT-NGF was found to be quickly released at the
first day, whereas LBD-NGF could gradually release from laminin
during 6 days. These results demonstrated the LBD-NGF could be
retained on laminin for a longer time compared with NAT-NGF.
We subsequently evaluated whether the bioactivity of NGF-b
was influenced during the genetic engineering process. PC12 cells
were used for examining the bioactivities of the refolded LBD-
NGF by neurite outgrowth assay and MTT assay. The results
showed that LBD-NGF retained the bioactivity of NGF.
Bioactivity assay of NGF on laminin in vitro also demonstrated
that LBD-NGF maintained higher concentration and bioactivities
Figure 5. Histological analysis. (a–d) At week 8 after injury, the longitudinal sections of the control (a), NAT-NGF (b) and LBD-NGF group (c)
compared with that of native nerve group (d) analyzed by H.E. staining. (e–h) At week 8 after injury, immunostaining with anti-neurofilament
antibody in transverse sections of the control (e), NAT-NGF (f) and LBD-NGF group (g) compared with that of native nerve group (h). (i–l) At week 8
after injury, immunotaining of the Schwann cell marker S100 in the transverse sections of the control (i), NAT-NGF (j) and LBD-NGF group (k)
compared with that of native nerve group (l). (m) The statistical analysis of neurofilament-positive area of each group. (n) The statistical analysiso f
S100-positive area of each group. n=6, *, P,0.05, **, P,0.01, determined by two-tailed student’s t-test.
doi:10.1371/journal.pone.0006180.g005
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laminin and could be helpful in nerve injury repair.
The rat sciatic nerve crush injury model was used to test the
effect of nerve injury repair by LBD-NGF. In order to limit
additional variations, such as the surgical technique, mismatch of
proximal and distal axonal alignment and foreign body (suture)
reaction, we chose a pure crush injury model in the study. Sciatic
nerve crush injuries caused anatomical disruption of axons.
Wallerian degeneration occured when there was a disruption of
the axon [32,33]. The distal portion of the axon and myelin
degenerated [34]. Therefore, this model provided a feasible system
for studying the nerve regeneration, remyelination, and functional
alterations associated with peripheral nerve injuries. In addition,
this model partially maintained the continuity of the nerve. Thus,
the nerve extracellular matrix component laminin could be
utilized as the target as well as the scaffold for nerve regeneration.
Functional assay by walking track analysis, histological analysis,
and electrophysiological evaluation were the most commonly used
assays to evaluate nerve regeneration in this model [35–37].
LBD-NGF was retained at the injury sites, and the LBD-NGF
group demonstrated the most favorable functional recovery as
measured by SFI. The electrophysiological observation of LBD-
Figure 6. Remyelination of sciatic nerves. (a–d) Toluidine blue staining. At week 4 after injury, light micrographs of transverse semi-thin sections
at the injury sites of the control (a), NAT-NGF (b) and LBD-NGF group (c) compared with that of native nerve group (d). (e–h) Transmission electron
micrographs (TEMs). At week 12 after injury, ultra-thin sections at the injury sites of the control (a), NAT-NGF (b) and LBD-NGF group (c) compared
with that of native nerve group (d) were observed under TEM. (i) The statistical analysis of the number of myelinated axons. (j) The statistical analysis
of the myelinated axon diameter. (k) The statistical analysis of thickness of myelin sheath. Myelinated axons (M), unmyelinated axons (U) and
Schwann cells (S) surrounding the myelinated axons can be seen clearly. n=6, *, P,0.05, **, P,0.01, determined by two-tailed student’s t-test.
doi:10.1371/journal.pone.0006180.g006
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and DCMAP than NAT-NGF and the control groups correlated
well with the functional SFI findings. In addition, the histological
findings indicated that the LBD-NGF group showed better
regeneration in axonal regeneration, Schwann cell proliferation
and remyelination of sciatic nerves. Thus the in vivo work
demonstrated that laminin binding NGF targeted specifically to
the endogenous laminin of the sciatic nerves and maintained a
higher concentration and stronger bioactivity of NGF at the injury
sites. It was effective in enhancing histologically detectable nerve
regeneration and improving functional recovery.
For nerve injuries such as crush and stretch, LBD-NGF could be
directly utilized for repair by using the native nerve extracellular
matrix component laminin as the target as well as the scaffold.
However, if the nerve injury is extensive, forming an irreducible gap
between the injured proximal and distal stumps, a nerve bridge
technique would be preferred. Scaffolding biomaterials filled with
laminin or laminin-rich biomaterials which can aid in the guidance
of growing nerve fibers along appropriate paths could be used to
enhance the precision of stump approximation. At the same time,
the laminin binding NGF could be used to promote nerve
regeneration and improve functional recovery. Laminin-rich nerve
bridging scaffolds and the laminin binding NGF could be an
effective strategy for the repair of severe nerve injuries.
In conclusion, LBD-NGF promoted sciatic nerve regeneration.
LBD-NGF maintained a higher concentration and stronger
bioactivity on laminin. Using a rat sciatic nerve crush injury
model, LBD-NGF was found to be retained and concentrated at
the nerve injury sites to enhance the functional restoration
following nerve damages. The laminin binding NGF targeted to
the nerve extracellular matrix laminin and promoted the repair of
peripheral nerve injuries.
Materials and Methods
Engineering and preparation of NGF
Gene of NAT-NGF or LBD-NGF was generated by PCR and
inserted into vector pET-28a (Novagen), respectively. BL21 (DE3)
strain of E. coli was transformed targeted vector, and then we
induced the protein of NAT-NGF or LBD-NGF with 1 mM
isopropyl b-D-thiogalactopyranoside (IPTG) at 37uC for 5 h. we
harvested the two recombinant proteins accumulating in the
inclusion bodies from cell lysis by centrifugation and solubilized in
8 M urea containing 0.4% (vol/vol) b-Mercaptoethanol. Purifica-
tion of the solubilized fusion proteins was then accomplished
under denaturing conditions by nickel chelate chromatography
(Amersham Biosciences). The expression of recombinant proteins
was analyzed by electrophoresis on a 15% (wt/vol) sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under
reducing condition and western-blotting with mouse antibody to
polyhistidine (1:1,000 dilution; Sigma) and sheep antibody to
mouse Alkaline phosphatase (1:10,000 dilution; Sigma). The
purified NAT-NGF or LBD-NGF was refolded in the glutathione
redox-refolding system by chromatographic method [38], then
stored at 280uC. Protein concentration was monitored by the
method of Bradford utilizing bovine serum albumin (BSA) as a
standard [39].
Laminin binding assay in vitro
The laminin binding assay was carried out by a modified ELISA
assay [40,41]. We added laminin (Sigma) previously to 96-well
plates (Costar), and then incubated the plates at 4uC for 24 h and
ventilated dry after discarding the redundant solution, followed by
washing for 3 times with PBS (pH 7.3). we blocked the plates with
2.5% (wt/vol) BSA containing 0.1% (vol/vol) Tween 20 at 37uC
for 2 h. Recombinant proteins with increasing concentrations
were added to the plates (100 ml/well) and incubated at 37uC for
2 h, and then washed for 3 times to remove the unbound proteins.
Mouse monoclonal antibody to polyhistidine (1:1,000 dilution;
Sigma) was added and incubated at 37uC for 1 h. The unbound
primary antibodies were removed by three washes as above. Sheep
antibody to mouse Alkaline phosphatase (1:10,000 dilution; Sigma)
was added to incubate at 37uC for 1 h. After three washes as
above, bound proteins were detected by the alkaline phosphatase
(AP) reaction with para-nitrophenylphosphate (pNPP) (Sigma) in
AP buffer (pH 9.6) for 15 min at 37uC. The results were
quantified at 405 nm using an ELISA reader (Molecular Devices).
We calculated the dissociation constant Kd values for two proteins
binding to laminin as described previously[42].
Sustained release assay of NGF from laminin in vitro
In this study, we prepared the laminin containing membranes
from pig amnion [43,44]. We tested the laminin content of the
scaffold by ELASA assay. Antibody to laminin (1:1,000 dilution;
Abcam) was used in this experiment. Laminin (20 mg/ml)
purchased from Sigma-Aldrich. Inc was used as the positive
control. Then the laminin membranes (6-mm diameter) were
loaded with 0.05 nmol NAT-NGF or LBD-NGF respectively, and
placed in 48-well plates. The membranes were suspended in
500 mL PBS and incubated on a rocker platform (37uC, 80 g). PBS
in 48-well plates was changed every 12 h. At each time point from
day 0 to 8, we collected the samples and analyzed the NAT-NGF
and LBD-NGF retained on the membranes by ELISA assay.
Bioactivity assay of NGF in vitro
We measured the bioactivity of NAT-NGF and LBD-NGF
using PC12 cells (purchased from the Peking Union Medical
College) in cell neurite outgrowth assay [45,46] and MTT assay
[47]. PC12 cells were seeded in polylysine-treated 48-well plates
(Costar) at the density of 5610
3 cells/well and maintained under
serum-free RPMI 1640 medium (HyClone) at 37uC for 1 h, then
serially diluted refolded NAT-NGF or LBD-NGF was added to
the plates. After 24 h incubation, the percentage of cells with
neurites more than the average diameter of the cell in length was
determined. The number of surviving cells was determined by
MTT assay after 72 h culture with NAT-NGF or LBD-NGF.
Cells cultured under identical conditions but without NGF served
as a blank control. The assay was valued in duplicate by two
independent assessors.
Bioactivity assay of NGF on laminin in vitro
In this study, laminin-coated 48-well plates (Costar) were
incubated with NAT-NGF or LBD-NGF at 4uC for 1 h, and then
the plates were extensively washed. PC12 cells were seeded at the
density of 5610
3 cells/well under the same condition as described
above. After 24 h incubation, the percentage of cells with neurites
more than the average diameter of the cell in length was
determined. The number of surviving cells was also determined
by MTT assay after 72 h culture. Cells cultured under identical
conditions but without NGF served as a blank control. The assay
was valued in duplicate by two independent assessors.
Laminin content evaluation in rat sciatic nerve
Six rats were sacrificed by cervical dislocation. The sciatic
nerves about 1 cm of 3 rats were rapidly excised and fixed in 4%
(vol/vol) formaldehyde for 48 h. we embedded the samples in
paraffin and 5-mm sections and examined the samples by
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tion; Chemicon). The sciatic nerves about 1 cm of the other 3 rats
were also excised, frozen immediately in liquid nitrogen. Then we
extracted the proteins for western-blotting analysis. In the analysis,
we used the antibody to laminin (1:2,000 dilution; Chemicon) to
test the laminin content in the rat sciatic nerve. At the same time,
we used laminin (10 mg) purchased from Sigma-Aldrich.Inc as the
positive control.
Surgical Procedures and application of NGF
To test the laminin binding ability and biological function of
NAT-NGF and LBD-NGF in vivo, we used a rat sciatic nerve crush
injury model. Seventy-eight male Sprague-Dawley rats weighting
200–220 g were anesthetized by an intraperitoneal injection of
sodium pentobarbital (40 mg/kg body weight) and the hair on the
right femur was removed. After sterilization, subcutaneously an
incision was made at the thigh. Right sciatic nerve was carefully
exposed from the intermuscular space, isolated, and subsequently
crushed a 5 mm segment for 10 s above the bifurcation of the
sciatic nerve with a hemostatic forceps. Then we used a non-
degradable suture to mark the site of the lesion at the epineurium.
10 ml NAT-NGF (30 mM) or LBD-NGF (30 mM) was injected into
the injury sites respectively. We injected PBS as negative control.
Finally, we sutured the fascia and skin separately. During these
animal experiments, we observed the Chinese Ministry of Public
Health (CMPH) Guide and US National Institute of Health (NIH)
Guide for the care and use of laboratory animals. All animals were
kept under standardized laboratory conditions in an air-condi-
tioned room with free access to food and water. At different time
points, the rats were sacrificed by cervical dislocation.
Laminin binding assay of NGF in vivo
Three hours and twelve hours after injection of NAT-NGF or
LBD-NGF,24ratsweresacrificedbycervicaldislocation.Weexcised
the injured sciatic nerves about 1 cm, frozen them immediately in
liquid nitrogen. Then we extracted proteins for western blot analysis.
Antibody to polyhistidine (1:1,000 dilution; Sigma) was used to
distinguish exogenous proteins from endogenous proteins.
Walking track analysis
We assessed the functional nerve recovery following sciatic
nerve injury using rat walking track analysis by recording its
footprints. At days 0, 7, 11, 14, 18, 21, 25, 28, 35, 42, 49, 56, 70
after nerve injury the animals were submitted to walking track
analysis and measurement of the SFI using a method described by
Bain et al [37]. We could calculate the SFI based on the following
formula:
SFI~{38:3 ½(EPL{NPL)=NPL 
z 109:5 ½(ETS{NTS)=NTS 
z 13:3 ½(EIT{NIT)=NIT {8:8:
Where EPL indicated the operated experimental paw length;
NPL, normal paw length; ETS, operated experimental toe spread,
i.e., the distance between the first and fifth toes; NTS, the normal
toe spread; EIT, the operated experimental intermediary toe
spread, i.e., the distance between the second and fourth toes; and
NIT, normal intermediary toe spread. The SFI was scaled such
that 2100 represented the sciatic nerve was crushed completely
and 0 represented normal function or completely recovery [48].
The evaluations of all animals were performed by a single
investigator blinded to the experiments.
Electrophysiological evaluation
We performed the electrophysiological evaluation before,
immediately after, and weeks 4, 8, 12 after the sciatic nerve
injury. In this experiment we evaluated two parameters, NCV and
DCMAP. Under anesthesia, the rats’ sciatic nerves were exposed.
Monopolar recording electrode and bipolar stimulating electrodes
were used to induce and record electrical activity. We recorded
NCV and DCMAP in responding to the stimuli using EMG
recorder (Medelec Synergy, Oxford Instruments). The following
settings were used: Low Filter, 3 Hz; High Filter, 10 KHz;
Sensitivity, 0.1 mV; Sweep duration, 10 ms.
Histological analysis
We performed the morphological assessments at weeks 4, 8 and
12 after sciatic nerve injury. The sciatic nerves (about 1 cm) at the
injury sites were rapidly excised and fixed in 4% (vol/vol)
formaldehyde for 48 h. The segments were embedded in paraffin
and 5-mm sections were cut from each segment examined by H.E.
staining and immunohistochemistry using antibodies to neurofila-
ment (1:100 dilution; Thermo) and S100 (1:2,000 dilution; Sigma).
Using Image-Pro Plus software (Media Cybernetics), we performed
the quantification of neurofilament-positive and S100-positive area
from at least 6 randomly selected fields at 4006magnification.
We stained the transverse semi-thin sections (1 mm thick) from
each segment with Toluidine blue and observed under a light
microscope (performed by Jinan Lujing Microscopic Technical
Center). The number of myelinated axons was counted from at
least 6 randomly selected fields under the magnification of 6400.
Using Image-Pro Plus software (Media Cybernetics), we evaluated
the myelinated axon diameter at 4006 magnification. Ultra-thin
sections (70 nm thick) were observed under transmission electron
microscope (performed by Jinan Lujing Microscopic Technical
Center). We also evaluated the thickness of myelin sheath by
Image-Pro Plus software (Media Cybernetics).
Statistical analysis
Data were presented as mean values6standard deviation. The
statistical significance of differences in parameters was determined
as *P,0.05 and **P,0.01, by two tailed student’s t-test.
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